Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Pathology

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.2929PMID 21710693PMCID PMC3793840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.

  2011cited by this paper
• Establishment and genomic characterization of mouse xenografts of human primary prostate tumors.

  2010cited by this paper
• Cancer Statistics, 2009

  2010cited by this paper
• Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRβ/B-RAF

  2010cited by this paper
• The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma

  2010cited by this paper
• Retracted: Immunotherapy of metastatic renal cell carcinoma

  2009cited by this paper
• Familial renal adenomas in Wistar rats; a preliminary report.

  2009cited by this paper
• Incidence and long-term prognosis of papillary renal cell carcinoma

  2009cited by this paper
• VHL gene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma

  2009cited by this paper
• Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.

  2009cited by this paper
• Vascular endothelial growth factor‐targeted therapy in metastatic renal cell carcinoma

  2009cited by this paper
• Renal cell carcinoma

  2009cited by this paper
• Prognostic factors for survival in metastatic renal cell carcinoma

  2009cited by this paper
• Immunotherapy of Metastatic Renal Cell Carcinoma

  2008cited by this paper
• Mouse xenograft models vs GEM models for human cancer therapeutics

  2008cited by this paper
• Rising incidence of small renal masses: a need to reassess treatment effect.

  2007cited by this paper
• Immunotherapy for metastatic renal cell carcinoma

  2007cited by this paper
• Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model

  2007cited by this paper
• The Role of Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cancer

  2007cited by this paper
• Five‐year survival after surgical treatment for kidney cancer

  2007cited by this paper
• Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.

  2007cited by this paper
• Profiling and classification tree applied to renal epithelial tumours

  2007cited by this paper
• Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

  2007cited by this paper
• Epidemiologic aspects of renal cell carcinoma.

  2006cited by this paper
• Development and characterization of efficient xenograft models for benign and malignant human prostate tissue

  2005cited by this paper
• Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer

  2005cited by this paper
• Systemic therapy for renal cell carcinoma.

  2005cited by this paper
• The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.

  2005cited by this paper
• Renal-cell carcinoma.

  2005cited by this paper
• Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.

  2005cited by this paper
• Genetic Basis of Cancer of the Kidney

  2004influential reference
• CD10 is a diagnostic and prognostic marker in renal malignancies

  2004cited by this paper
• A clinically relevant orthotopic implantation nude mouse model of human epithelial ovarian cancer—based on consecutive observation

  2004cited by this paper
• Short-Term Human Prostate Primary Xenografts

  2004cited by this paper
• BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

  2004cited by this paper
• Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

  2003cited by this paper
• Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans: Better than Commonly Perceived—But They Can Be Improved

  2003cited by this paper
• CD34− Blood‐Derived Human Endothelial Cell Progenitors

  2001cited by this paper
• Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

  2001cited by this paper
• Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases.

  2001cited by this paper
• Systemic therapy for renal cell carcinoma.

  2000cited by this paper
• A Novel “Nihon'’Rat Model of a Mendelian Dominantly Inherited Renal Cell Carcinoma

  2000cited by this paper
• Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.

  1999cited by this paper
• Orthotopic Models are Necessary to Predict Therapy of Transplantable Tumors in Mice

  1998cited by this paper
• Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation

  1998cited by this paper
• Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.

  1998cited by this paper
• Orthotopic implantation of colon carcinoma cells provides an experimental model in the rat that replicates the regional spreading pattern of human colorectal cancer.

  1998cited by this paper
• Prognostic value of Ki-67 expression in renal cell carcinomas.

  1997cited by this paper
• Renal-cell carcinoma.

  1996cited by this paper
• Hereditary renal cell carcinoma in the Eker rat: a unique animal model for the study of cancer susceptibility.

  1995cited by this paper
• Cancer seed and soil can be highly selective: human-patient colon tumor lung metastasis grows in nude mouse lung but not colon or subcutis.

  1995cited by this paper
• Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.

  1995cited by this paper
• Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.

  1995cited by this paper
• Chemotherapy for advanced renal-cell carcinoma: 1983-1993.

  1995cited by this paper
• Molecular cytogenetics of renal cell tumors.

  1993cited by this paper
• Immunotherapy for metastatic renal cell carcinoma.

  1993cited by this paper
• Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts.

  1990cited by this paper
• Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• The international histological classification of tumours.

  1981cited by this paper
• Hereditary renal adenomas and adenocarcinomas in rats.

  1981cited by this paper
• Membrane Potential of Brown Adipose Tissue

  1968cited by this paper
• Renal cell carcinoma.

  1956influential reference

• Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells

  2025cites this paper
• Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic

  2025cites this paper
• Patient-Derived Renal Cell Carcinoma Xenografts Capture Tumor Genetic Profiles and Aggressive Behaviors

  2022cites this paper
• Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics

  2022cites this paper
• Establishment of a ccRCC patient-derived chick chorioallantoic membrane model for drug testing

  2022cites this paper
• Patient-derived xenograft (PDX) models, applications and challenges in cancer research

  2022cites this paper
• Preclinical models for development of immune-oncology therapies.

  2022cites this paper
• A renal cell carcinoma tumorgraft platform to advance precision medicine

  2021cites this paper
• Xenograft models for pediatric cancer therapies

  2021cites this paper
• Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma

  2021cites this paper
• Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma

  2020cites this paper
• Humanized Rodent Models for Cancer Research

  2020cites this paper
• Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications

  2020cites this paper
• Choosing The Right Animal Model for Renal Cancer Research☆

  2020cites this paper
• Patient-derived xenograft models to optimize kidney cancer therapies.

  2019influential citation
• Patient-Derived Xenografts in Oncology

  2017cites this paper
• Patient-derived xenografts as in vivo models for research in urological malignancies

  2017cites this paper
• Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI

  2017cites this paper
• Nephroblastoma overexpressed gene expression and its prognostic implications of clinical outcomes in renal cell carcinoma patients

  2017cites this paper
• Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma

  2016cites this paper
• Recreating complex pathophysiologies in vitro with extracellular matrix surrogates for anticancer therapeutics screening.

  2016cites this paper
• Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer

  2015cites this paper
• Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity.

  2015cites this paper
• Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo

  2015cites this paper
• AWARD NUMBER: W81XWH-12-1-0328 TITLE: Hyperpolarized 13C MR Markers of Renal Tumor Aggressiveness PRINCIPAL INVESTIGATOR: Dr. Renuka Sriram CONTRACTING ORGANIZATION: University of California, San Francisco

  2014cites this paper
• Tissue slice grafts of human renal cell carcinoma: an authentic preclinical model with high engraftment rate and metastatic potential.

  2014cites this paper
• Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing

  2014cites this paper
• Development of a realistic in vivo bone metastasis model of human renal cell carcinoma

  2014cites this paper
• Stability of preclinical models of aggressive renal cell carcinomas.

  2014cites this paper
• Tumor Microenvironment in Human Tumor Xenografted Mouse Models

  2014cites this paper
• Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer

  2013cites this paper
• Origin of the vasculature supporting growth of primary patient tumor xenografts

  2013cites this paper
• MR markers of renal tumor aggressiveness PRINCIPAL INVESTIGATOR :

  2013cites this paper
• Hyperpolarized 13C MR Markers of Renal Tumor Aggressiveness

  2013cites this paper
• Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)

  2012cites this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cites this paper
• A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

  2012cites this paper
• Extracellular protease imaging for cell mass tracking of xenografted human malignant pleural mesothelioma.

  2012cites this paper